文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

采用温和热疗优化的隐形热敏脂质体触发内容释放。

Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.

机构信息

Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.

出版信息

J Control Release. 2010 Apr 19;143(2):274-9. doi: 10.1016/j.jconrel.2010.01.006. Epub 2010 Jan 13.


DOI:10.1016/j.jconrel.2010.01.006
PMID:20074595
Abstract

Liposomes are potent nanocarriers to deliver chemotherapeutic drugs to tumors. However, the inefficient drug release hinders their application. Thermosensitive liposomes (TSL) can release drugs upon heat. This study aims to identify the optimum 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-PEG(2000) (DSPE-PEG(2000)) concentration in stealth TSL to improve content release efficiency under mild hyperthermia (HT). TSL were prepared with DSPE-PEG(2000) from 1 to 10 mol%, around 80 nm in size. Quenched carboxyfluorescein (CF) in aqueous phase represented encapsulated drugs. In vitro temperature/time-dependent CF release and TSL stability in serum were quantified by fluorometry. In vivo CF release in dorsal skin flap window chamber models implanted with human BLM melanoma was captured by confocal microscopy. In vitro heat triggered CF release increased with increasing DSPE-PEG(2000) density. However, 6 mol% and higher DSPE-PEG(2000) caused CF leakage at physiological temperature. TSL with 5 mol% DSPE-PEG(2000) were stable at 37 degrees C, while released 60% CF in 1 min and almost 100% CF in 1h at 42 degrees C. In vivo optical intravital imaging showed immediate massive CF release above 41 degrees C. In conclusion, incorporation of 5 mol% DSPE-PEG(2000) optimized stealth TSL content release triggered by HT.

摘要

脂质体是一种有效的纳米载体,可将化疗药物递送到肿瘤部位。然而,药物释放效率低下限制了其应用。热敏脂质体(TSL)可以在加热时释放药物。本研究旨在确定隐形 TSL 中最佳的 1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺-N-聚乙二醇(2000)(DSPE-PEG(2000))浓度,以提高温和热疗(HT)下的药物内容物释放效率。使用 DSPE-PEG(2000)从 1 至 10mol%制备 TSL,粒径约为 80nm。水相中的猝灭羧基荧光素(CF)代表包封的药物。通过荧光法定量测量体外温度/时间依赖性 CF 释放和 TSL 在血清中的稳定性。通过共聚焦显微镜捕获植入人 BLM 黑色素瘤的背部皮瓣窗口室模型中的体内 CF 释放。体外热触发 CF 释放随 DSPE-PEG(2000)密度的增加而增加。然而,6mol%及更高浓度的 DSPE-PEG(2000)会导致在生理温度下 CF 泄漏。含 5mol% DSPE-PEG(2000)的 TSL 在 37°C 时稳定,而在 42°C 下 1 分钟内释放 60%CF,1 小时内几乎释放 100%CF。体内光学活体成像显示,在 41°C 以上时立即大量释放 CF。总之,在 HT 触发下,掺入 5mol% DSPE-PEG(2000)可优化隐形 TSL 的内容物释放。

相似文献

[1]
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.

J Control Release. 2010-1-13

[2]
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.

J Control Release. 2013-3-21

[3]
Size of thermosensitive liposomes influences content release.

J Control Release. 2010-8-19

[4]
Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.

J Control Release. 2012-7-1

[5]
Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.

J Control Release. 2015-11-3

[6]
MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.

Invest Radiol. 2008-12

[7]
Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate.

Bioorg Med Chem. 2010-6-18

[8]
Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.

Pharm Res. 2015-12

[9]
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.

J Control Release. 2009-10-9

[10]
Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.

Int J Pharm. 2014-11-20

引用本文的文献

[1]
Triple synergistic enhancement of breast cancer treatment via chemotherapy, chemodynamic therapy, and tumor starvation therapy driven by lipid-COF nanoparticles.

Sci Rep. 2025-3-21

[2]
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.

Int J Nanomedicine. 2025-1-31

[3]
Mild Hyperthermia Enhanced Liposomal Doxorubicin Delivery and CD8 T cell Infiltration in Triple Negative Breast Cancer.

bioRxiv. 2024-4-27

[4]
Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications.

ACS Appl Bio Mater. 2024-5-20

[5]
Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies.

Sci Adv. 2024-4-12

[6]
A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells.

Pharmaceutics. 2023-8-31

[7]
Review of the Delivery Kinetics of Thermosensitive Liposomes.

Cancers (Basel). 2023-1-7

[8]
Thermosensitive Liposomes Encapsulating Nedaplatin and Picoplatin Demonstrate Enhanced Cytotoxicity against Breast Cancer Cells.

ACS Omega. 2022-11-7

[9]
Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience.

Pharmaceutics. 2022-10-11

[10]
Selecting ideal drugs for encapsulation in thermosensitive liposomes and other triggered nanoparticles.

Int J Hyperthermia. 2022

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索